Indicated for: alpha-1 antitrypsin deficiency
Route of administration: infusion
Substance: human alfa-1 proteinase inhibitor (alpha-1 proteinase inhibitor)
ATC: B02AB02 (Blood and blood forming organs | Antifibrinolytics | Proteinase inhibitors)
Human alpha-1 proteinase inhibitor is used for the treatment of alpha-1 antitrypsin deficiency, a genetic condition that can lead to lung diseases such as emphysema. It works by protecting lung tissue from enzymatic degradation.
The medication is administered intravenously, as directed by a doctor. It is important to monitor the patient for adverse reactions during the infusion.
Side effects may include headache, fever, dizziness, or injection site reactions. In rare cases, severe allergic reactions may occur.
This medication is not recommended for patients with hypersensitivity to human plasma proteins or severe IgA deficiency.